NASDAQ: FRTXFresh Tracks Therapeutics Inc Stock Ownership - Who owns Fresh Tracks Therapeutics?
Insider buying vs selling
Have Fresh Tracks Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when FRTX insiders and whales buy or sell their stock.
FRTX Shareholders
What type of owners hold Fresh Tracks Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| James R. Singer | 316.19% | 18,675,667 | $10.81M | Insider |
| Austin W. Greenhouse David M. Marxe | 208.53% | 12,316,695 | $7.13M | Insider |
| Armistice Capital LLC | 73.48% | 4,340,000 | $2.51M | Insider |
| Vsciences Investments Pte Ltd | 68.32% | 4,035,424 | $2.34M | Insider |
| Anges Mg Inc | 34.85% | 2,058,528 | $1.19M | Insider |
| Dennison T. Veru | 17.45% | 1,030,840 | $596.86k | Insider |
| Reginald L. Hardy | 12.96% | 765,285 | $443.10k | Insider |
| Robert Busard Brown | 5.36% | 316,659 | $183.35k | Insider |
| Igor Bilinsky | 3.28% | 193,798 | $112.21k | Insider |
| Jill Marie Broadfoot | 2.47% | 145,649 | $84.33k | Insider |
FRTX vs Biotech Stocks
Fresh Tracks Therapeutics Stock Ownership FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.